Cargando…

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs

For developing oral drugs, it is necessary to predict the oral absorption of new chemical entities accurately. However, it is difficult because of the involvement of efflux transporters, including P-glycoprotein (P-gp), in their absorption process. In this study, we conducted a comparative analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kono, Yusuke, Kawahara, Iichiro, Shinozaki, Kohei, Nomura, Ikuo, Marutani, Honoka, Yamamoto, Akira, Fujita, Takuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999658/ https://www.ncbi.nlm.nih.gov/pubmed/33804018 http://dx.doi.org/10.3390/pharmaceutics13030388

Ejemplares similares

Assessment of contribution of BCRP to intestinal absorption of various drugs using portal‐systemic blood concentration difference model in mice
por: Kawahara, Iichiro, et al.
Publicado: (2020)

Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein
por: Morishita, Hiroki, et al.
Publicado: (2020)

ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
por: Rösch, Lisa, et al.
Publicado: (2022)

Generating Inhibitors of P-Glycoprotein: Where to, Now?
por: Crowley, Emily, et al.
Publicado: (2009)

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
por: Veiga-Matos, Jéssica, et al.
Publicado: (2023)

Identification and characterization of primate P-glycoprotein
por: Yimam, Mesfin
Publicado: (2015)

An Investigation into the Role of P-Glycoprotein in the Intestinal Absorption of Repaglinide: Assessed by Everted Gut Sac and Caco-2 Cell Line
por: Yaghoobian, Morteza, et al.
Publicado: (2019)

Marine Natural Products with P-Glycoprotein Inhibitor Properties
por: Lopez, Dioxelis, et al.
Publicado: (2014)

Natural Inhibitors of P-glycoprotein in Acute Myeloid Leukemia
por: Labbozzetta, Manuela, et al.
Publicado: (2023)

Permeability of Ciprofloxacin-Loaded Polymeric Micelles Including Ginsenoside as P-glycoprotein Inhibitor through a Caco-2 Cells Monolayer as an Intestinal Absorption Model
por: Sharif Makhmal Zadeh, Behzad, et al.
Publicado: (2018)

Interaction of Docetaxel (“Taxotere”) with Human P‐Glycoprotein
por: Shirakawa, Katsuro, et al.
Publicado: (1999)

P-glycoprotein and chronic rhinosinusitis
por: Miyake, Marcel M., et al.
Publicado: (2018)

Regulation of P-Glycoprotein in the Brain
por: Chai, Amanda B., et al.
Publicado: (2022)

Pulchinenosides from Pulsatilla Chinensis Increase P-Glycoprotein Activity and Induce P-Glycoprotein Expression
por: Liu, Yali, et al.
Publicado: (2020)

Overexpression of P-glycoprotein, MRP2, and CYP3A4 impairs intestinal absorption of octreotide in rats with portal hypertension
por: Sun, Xiaoyu, et al.
Publicado: (2021)

Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis
por: Foley, Sage E., et al.
Publicado: (2021)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Inostamycin, an Inhibitor of P‐Glycoprotein Function, Interacts Specifically with Phosphatidylethanolamine
por: Kawada, Manabu, et al.
Publicado: (1995)

Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)

Conformation of membrane-inserted P-glycoprotein
por: Stockner, Thomas, et al.
Publicado: (2010)

Is Ciprofloxacin a Substrate of P-glycoprotein?
por: Park, Miki Susanto, et al.
Publicado: (2011)

An immunohistochemical analysis of P-glycoprotein in retinoblastoma
por: Sethi, Sumita, et al.
Publicado: (2012)

Refined structures of mouse P-glycoprotein
por: Li, Jingzhi, et al.
Publicado: (2014)

P-glycoprotein transporter in drug development
por: Prachayasittikul, Veda, et al.
Publicado: (2016)

The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
por: Gao, Wei, et al.
Publicado: (2014)

Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors
por: Poongavanam, Vasanthanathan, et al.
Publicado: (2012)

Ligand and Structure-Based Classification Models for Prediction of P-Glycoprotein Inhibitors
por: Klepsch, Freya, et al.
Publicado: (2013)

New fluphenazine analogues as inhibitors of P-glycoprotein in human lymphocyte cultures
por: Jaszczyszyn, Agata, et al.
Publicado: (2012)

Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir
por: Rehman, Saleha, et al.
Publicado: (2017)

Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
por: Zu, Yaqiong, et al.
Publicado: (2014)

Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds
por: Mora Lagares, Liadys, et al.
Publicado: (2019)

P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors
por: Kopecka, Joanna, et al.
Publicado: (2016)

Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death
por: Kopecka, Joanna, et al.
Publicado: (2020)

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
por: Ruponen, Marika, et al.
Publicado: (2021)

Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance
por: Marques, Sérgio M., et al.
Publicado: (2021)

Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2021)

Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
por: Kwon, Mihwa, et al.
Publicado: (2020)

Sex Differences in Intestinal P-Glycoprotein Expression in Wistar versus Sprague Dawley Rats
por: Madla, Christine M., et al.
Publicado: (2022)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
por: Cho, Hyun-Jong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_89v0fe3cpupg7f810pfqthsirn